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Summary DNA measurements on biopsy material from 24 squamous cell carcinomas of the oral cavity given
preoperative radiotherapy indicate that DNA aneuploid tumours respond better to radiotherapy than do
diploid and polyploid tumours. The mean S-phase value was higher (16.1%) for 8 tumours that were
eradicated by preoperative radiotherapy than for 13 that did not respond (8.1%). These factors correlated
better with the response than did histological and clinical (T) classifications.
DNA-ploidy and S-phase estimation can complement the histological diagnosis, and may prove valuable
when planning treatment.
It is well known that tumours of similar macro-
and microscopical appearance do not always
respond similarly to radiotherapy. An objective
predictor of the irradiation response would be of
great value when planning the treatment.
Reduction in tumour volume has been used as a
prognostic criterion in radiotherapy (Grossman et
al., 1973; Mantyla et al., 1979). The regression rate
after 40-45Gy of irradiation is assumed to be
important when deciding whether to continue
radiotherapy or to change treatment modality
(Lederman, 1972). It has, however, been proposed
that this decision can be made already after 1OGy,
a clinical regression of more than 10% being
considered an indicator of radioresponsiveness
(Arcangeli et al., 1980). The correlation between
reduction in size and response to radiotherapy does
not apply to tumours with different histology and
site, and does not always hold for tumours with the
same histology and site, such as squamous cell
carcinomas of categories T3-T4 arising within the
head and neck (Friedman, 1974).
A decrease in thymidine labelling index (LI) by
more than 60% of the pretreatment value after
15Gy within 10 days has been said to be a good
prognostic indicator (Fettig et al., 1973). The same
figures were reported by Molinari et al. (1984), who
noted a higher complete regression rate in patients
whose tumour proliferative activity was reduced by
70% or more after 1OGy of radiotherapy. Another
interesting finding was the correlation between LI
reduction and long-term response. However,
opinions vary: Courdi and co-workers (1980)
observed the reverse relation between LI reduction
and tumour regression during radiotherapy and 5-
year survival.
DNA measurements have been used to predict
response to radiotherapy. Rutgers (1985) found that
determinations of the ploidy level of the main cell
line in a tumour can complement the histological
classification and add to the understanding of in
vivo irradiation effects in human tumours. In 15
squamous cell carcinomas of the uterine cervix, Lin
et al. (1984) found that radioresistent cells were
non-cycling DNA diploid cells; they found that the
mean value of the 2c cell population before
irradiation may be used as a parameter to foretell
radiosensitivity.
The aim of the present study was to see whether
determinations of DNA ploidy and S-phase in
diagnostic biopsy specimens from oral cavity carci-
nomas could assist in predicting the responsiveness
to preoperative radiotherapy.
Material and methods
Material
Biopsy specimens from 24 patients with squamous
cell carcinomas of the oral cavity taken for routine
histopathological examination during 1978-1983
were studied. In addition the operation specimens
were examined. All except one patient had received
40-44Gy of preoperative radiotherapy.
Irradiation technique
Irradiation was accomplished using 4 or 6 MV
linear accelerator. The target volume included
primary tumour and uni- or bilateral neck nodes
depending on primary tumour location. The
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treatment technique included anterior and one or
two lateral oblique fields with wedge filters. The
target absorbed doses are shown in Table I. CT-
scans, in at least three levels of the treatment
volume, were used as a basis for the dose planning.
Intra-oral and oesophageal thermoluminescence
dosimetry (TLD) measurments were performed
routinely to confirm calculated target absorbed
doses.
Table I Histologically assessed response to radiotherapy
in relation to target absorbed dose (Gy)
Target absorbed dose (Gy)
Tumour response to
radiotherapy 34 40 42 44
Eradicated (8) la 5 0 2
Moderate response (3) 0 1 0 2
No response (13) 0 3 1 9
aThis patient received 34Gy only to reduce the risk for
post-operative complications as primary mandibular
reconstruction was planned.
Preparation
Selected tumour areas in 50tim-thick sections from
the formalin-fixed, paraffin-embedded blocks were
prepared as described by Hedley et al. (1983),
except that the specimens were cytocentrifuged onto
object glasses and stained with Hoechst 33258.
Twenty-four preradiological and 16 postradiological
specimens were prepared; in 8 specimens no tumour
remained after radiotherapy.
Histopathological examination
All specimens were examined by the same
pathologist. The biopsy specimens of the squamous
cell carcinomas were re-examined and classified as
well, moderately well, and poorly differentiated on
the basis of the cytological and structural picture.
Sections from the operation specimens were also
re-examined. Specimens with only fibrosis,
inflammation, and foreign body reaction were
classified as 'no remaining tumour'. In specimens
with remaining tumour, evaluation of the rate of
response to radiotherapy was based on the least
degenerated part of the tumour, and was graded
into 'no' or 'moderate response'. In 'moderate
response', nuclear pyknosis, cytoplasmic vacuoliza-
tion, and no signs of mitosis should be present,
and should contrast with the findings in the
primary biopsy material.
DNA measurements
Static cytophotometry was performed using a Leitz
MPV 3 cytophotometer and the Fluora programme
(Bjelkenkrantz et al., 1983). About 300 tumour
nuclei and 10-20 lymphocytes were measured in
each specimen.
DNA classification
From the histograms the following were evaluated.
1. DNA ploidy. The tumour stem cell peak in
relation to the reference peak (lymphocytes) was
defined as the DNA index.
(a) A stem cell peak of DNA index 0.85-1.15 is
defined as DNA diploid or near-diploid if
the tetraploid peak does not exceed 10% of
the diploid peak.
(b) A stem cell peak of DNA index 2 is defined
as DNA polyploid if there are
hypertetraploid nuclei, preferably of about
DNA index value 4. This is also the case if
the stem cell peak is 1 and the tetraploid
peak is 10% or more of the diploid peak.
(c) A stem cell peak of DNA index over 1.15
and under 1.85, or over 2.15 is labelled
DNA aneuploid.
2. S-phase. Nuclei with a value between the GO/I
and G2/M peaks were calculated manually,
when the GO/1 and G2/M peaks had been
defined, and divided by the total numbers of
nuclei in GO/1 +S-phase+G2/M. In DNA
polyploid tumours, the S-phase was determined
by looking at the cell population between the
DNA diploid and tetraploid peaks. In DNA
aneuploid tumours, the S-phase was subjectively
estimated taking an overlapping DNA diploid
G2/M peak into account.
Results
The DNA histograms of the 24 squamous cell
carcinomas were classified into 5 DNA diploid
(Figure 1, 2), 12 DNA polyploid (Figure 3, 4), and
7 DNA aneuploid tumours (Figure 5, 6). After
preoperative irradiation, no tumour remained in the
operation specimen in 1 of the 5 DNA diploid
tumours (Figure 2), in 2 of the 12 DNA polyploid
tumours (Figure 4), and in 5 (including the one
who received only 34Gy) of the 7 DNA aneuploid
tumours (Figure 6). In addition, moderate response
to radiotherapy was noted in 2 of the DNA
polyploid tumours and in 1 of the DNA aneuploid
(Table II).
The mean S-phase was 6.4% (2-14) for the DNA
diploid, 10.0% (1-30) for the DNA polyploid, and
19.1% (10-29) for the DNA aneuploid tumours.
The mean S-phase value for the group of tumours
eradicated by radiotherapy was 16.1% (3-29), and
8.1% (1-16) for those that did not respond. TheDNA EVALUATION TO PREDICT IRRADIATION RESPONSE
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Figure 1 DNA diploid or near-diploid tumour with minimal response to radiotherapy. (a +b). Biopsy
specimen of a tongue carcinoma (T2NlMO). The photomicrograph shows a well differentiated squamous cell
carcinoma (H&E, bar: 50,um), and the tumour has a DNA diploid pattern. (c+d). Operation specimen 4
weeks after preoperative radiotherapy (42Gy). The tumour shows a minimal response to the radiotherapy,
and the DNA pattern is unchanged (H&E, bar: 50pm).
Table II Response to radiotherapy in relation to DNA
ploidy
Response to radiotherapy
as assessed histologically
No
remaining Moderate No
DNA ploidy pattern tumour response response
DNA diploid (5) 1 0 4
DNA polyploid (12) 2 2 8
DNA aneuploid (7) 5 1 1
mean S-phase for tumours with moderate
histological response was 17.3% (10-30).
All 5 DNA diploid tumours were well
differentiated. Of the 12 DNA polyploid tumours 5
were well differentiated, 6 moderately well
differentiated, and 1 poorly differentiated. Of the 7
DNA aneuploid tumours 3 were well differentiated,
3 moderately well differentiated, and 1 poorly
differentiated. Of the 8 carcinomas eradicated by
preoperative radiotherapy 5 were well differentiated
and 3 moderately well differentiated (Table III).
In accordance with the TNM classification
(UICC, 1978) the following emerged. Of the 5
DNA diploid tumours 3 were T2 and 2 T4; 3 had
lymph-node metastases. The 12 DNA polyploid
tumours comprised 1 TI and 7 T2, 3 T3 and 1 T4;
6 had lymph-node metastases. The 7 DNA
aneuploid tumours comprised 5 T2, 1 T3, and 1 T4;
4 had lymph-node metastases. Two of the 4 T4
tumours involved bone, and were therefore not only
classified according to size.
The tumours eradicated by radiotherapy
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Figure 2 DNA diploid or near-diploid tumour eradicated after preoperative radiotherapy. (a+b). Biopsy
specimen of a tongue carcinoma (T2NOMO). The photomicrograph shows a well differentiated squamous cell
carcinoma (H&E, bar: 50pum), and the tumour has a DNA diploid pattern. (c). Photomicrograph of the
operation specimen 4 weeks after preoperative radiotherapy (40Gy). There is no remaining tumour (H&E,
bar: 50 pm).
Table III Response to radiotherapy in relation to histopathological
differentiation
Response to radiotherapy
as assessedhistologically
No
remaining Moderate No
Histopathological grading tumour response response
Well differentiated (13) 5 0 8
Moderately differentiated (9) 3 3 3
Poorly differentiated (2) 0 0 2
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Figure 3 DNA polyploid tumour with minimal response to radiotherapy. (a +b). Biopsy specimen of a
tongue carcinoma (T2N1MO). The photomicrograph shows a moderately well differentiated squamous cell
carcinoma (H&E, bar: 50gm). The tumour has a DNA polyploid pattern. (c+d). Operation specimen 4
weeks after preoperative radiotherapy (44Gy), the remaining tumour shows minimal response to radiotherapy
(H&E, bar: 50pm), and the DNA pattern is unchanged.
Table IV Histologically assessed response to radiotherapy in relation
to tumour size (T) and lymph node metastases (N)
Lymph node
Tumour size (T) metastases (N)
Tumours response to
radiotherapy Ti T2 T3 T4 NO NJ
Eradicated (8) 0 6 1 1 4 4
Moderate response (3) 0 3 0 0 0 3
No response (13) 1 6 3 3 6 7
comprised 6 T2, 1 T3, and 1 T4 with bone
involvement; 4 had lymph-node metastases. The
non-responding tumours comprised 1 TI, 6 T2, 3
T3, and 3 T4; 1 tumour had bone involvement, 7 of
the 13 tumours had lymph node metastases. The 3
tumours with moderate response were all T2 and
had nodal involvement (Table IV).
Discussion
During the past decade efforts have been made to
find an objective measure to predict tumour
responsiveness to radiotherapy, such as reduction in
tumour size during the initial phase of irradiation
treatment (Arcangeli et al., 1980), reduction in
(a)
(c)
rF
I648 G. FRANZEN et al.
c2 Is
U
.0 A
z
(b)
1 2
ONAIh,ix
(c)
Figure 4 DNA polyploid tumour eradicated after preoperative radiotherapy. (a+b). Biopsy specimen of a
buccal carcinoma (T3NlM0). The photomicrograph shows a well differentiated squamous cell carcinoma
(H&E, bar: 50 pm) and the tumour has a DNA polyploid pattern. (c). Photomicrograph of the operation
specimen 4 weeks after preoperative radiotherapy (40Gy). There is no remaining tumour (H&E, bar: 50gm).
thymidine labelling index (Fettig et al., 1973;
Courdi et al., 1980; Molinari et al., 1984;
Klintenberg et al., 1985), and DNA determination
before, during, and after radiotherapy (Ganzer,
1974; Lin et al., 1984; Rutgers, 1985).
Inherent characteristics of cells form an
important basis for differences in radiosensitivity.
Other factors include oxygenation, radiation
damage repair potential, growth and proliferation
rates, variation in radiosensitivity during the cell-
cycle, and fractionation pattern. Tumour
heterogeneity assumes the existence of
subpopulations of cells with different geno- and
phenotypes resulting in cell clones with
characteristic radiosensitivity, and is considered a
major problem in the search for clinically reliable
cell kinetic criteria (Friedman, 1975).
Molinari et al. (1984) found that a decrease in
thymidine labelling index (LI) by 70% or more
after a 5-day course of radiotherapy (10Gy)
resulted in a higher rate of complete regression.
This reduction in LI corresponded to an 82% 3-
year disease-free survival, whereas all tumours
recurred within 19 months in patients in whom no
such LI reduction took place.
DNA measurements are superior to LI
estimations in that both DNA ploidy, S-phase, and
the occurrence of hypertetraploid nuclei can be
determined. Ganzer (1974) found no relationship
between the DNA distribution in malignant
tumours before, during, and after radiotherapy and
their response to treatment. He considered DNA
measurements not suitable for determining the
radiosensitivity of tumours. Ganzer's series,
however, included only 11 patients and comprised
different types of tumour, namely squamous cell
carcinoma, reticulosarcoma, and lymphoepithe-
lioma. More recent studies by Lin (1984) and
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Figure 5 DNA aneuploid tumour with minimal response to radiotherapy. (a+b). Biopsy specimen from a
carcinoma of the floor of the mouth (T3N1MO). The photomicrograph shows a poorly differentiated
squamous cell carcinoma (H&E, bar: 50pm). The tumour has a DNA aneuploid pattern. (c+d). Operation
specimen 4 weeks after preoperative radiotherapy (44Gy) with remaining tumour showing minimal response
to radiotherapy (H&E, bar: 50ym). The DNA histogram has changed, and mainly DNA diploid nuclei are
left after radiotherapy.
Rutgers (1985) indicate that determination of the
ploidy level of the main cell line in a tumour can
complement the histological classification, and that
the mean value of the 2c cell population before
irradiation could prove to be a clinically useful
predictor of radiosensitivity.
Trott (1980) stressed two major difficulties in
determining the response to radiotherapy during the
course of treatment.
1. After one-third of the treatment period more
than 99% of the remaining tumour consists of
doomed cells. It therefore seems impossible to-
assess the therapeutic response from biopsy
material removed during the course of
radiotherapy.
2. The heterogeneity of tumours makes it difficult
to obtain identical biopsy specimens on repeated
sampling.
In the present study we have evaluated pre-
treatment biopsy material and operation specimens
obtained 4 weeks after completion of the pre-
operative radiotherapy to avoid some of the
above mentioned problems.
The method of disintegrating nuclei from
formalin-fixed, paraffin-embedded material des-
cribed by Hedley et al. (1983), allows the retrospec-
tive study of adequate histopathological material
from patients in whom the clinical outcome is
known. DNA aneuploid tumours apparently
responded better to radiotherapy than did DNA
polyploid and DNA diploid tumours (Table II).
Accurate S-phase determinations are difficult using
static cytofluorometry as the number of nuclei
measured is limited. The S-phase was higher in
the aneuploid tumours. The mean S-phase value
was also higher in tumours that responded well
to radiotherapy (16.1%) than in those that did not
(a)
(c)
i INNNKE mL- E .
649
__
Pr--r-
I650 G. FRANZtN et al.
z
=c 40-
E
2Z20-
(b)
I
L .L
1 2
* r I
1. .1 I I .,
DNAIndex
Figure 6 DNA aneuploid tumour eradicated after preoperative radiotherapy. (a+b). Biopsy specimen of a
buccal carcinoma (T2NOMO). The photomicrograph shows a well-differentiated squamous cell carcinoma
(H&E, bar: 50,m). The tumour has a DNA aneuploid pattern. (c). Operation specimen 4 weeks after
preoperative radiotherapy (40Gy). There is no remaining tumour (H&E, bar: 50,um).
respond (8.1%). These figures tally with those of
Nusse (1981), who found the cells in the late
S-phase and the G2/M-phase to be those most
susceptible to radiotherapy. DNA aneuploid
tumours and a high S-phase are closely correlated
which makes it difficult to evaluate which of these
parameters has the greatest influence on the radio-
sensitivity. The estimation of the S-phase in DNA
polyploid tumours is difficult as it is impossible to
separate a DNA diploid tumour with prolonged
G2-phase and a DNA tetraploid tumour. Cell
doublets counted as a G2-phase or a tetraploid
peak can, however, be ruled out as the measure-
ments are performed under visual control, which
is the strength of static cytofluorometry versus
flow cytometry. According to Molinari et al. (1984),
the GO/Gl-phase is the period of the cell cycle
that has the longest duration (from hours to
months); this could be an alternative explanation
for the lower responsiveness of the diploid tumours.
An interesting finding was that of the 8
squamous cell carcinomas that were eradicated by
preoperative radiotherapy, 5 were well differen-
tiated (Figures 2, 4, 6) and 3 moderately well
differentiated. The two poorly differentiated
tumours (which could be assumed to be the most
radiosensitive) did not respond, at least not as
assessed histologically (Figure 5).
The size of the tumours and the presence of
lymph-node metastases did not apparently correlate
with the rate of response. There was no major
difference in size between the tumours that
responded to radiotherapy and those that did not.
There was an equal incidence of lymph-node
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metastases (- 50% in each group) in the group that
responded well to radiotherapy and in the group
that showed no response.
The present pilot study indicates that DNA
analysis may yield clinically applicable information
concerning response to radiotherapy. Further
investigations on a larger series of squemous cell
carcinomas of the head and neck is currently
performed, to see if the findings now presented can
be confirmed.
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